Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 156 participants.
Also called NCT04811651
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 156 participants
- Registry
-
NCT04811651
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT04811651. Randomized; quadruple masking; primary purpose treatment. Start 2021-03-15 (actual); primary completion 2024-07-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke
- Acronym
- UMSIS
- Condition
- Ischemic Stroke
- Intervention (Biological)
- Umbilical Cord-derived Mesenchymal Stem Cells
- Intervention (Drug)
- Placebo
- Lead sponsor
- General Hospital of Shenyang Military Region
Record details
- Record id
cardio:ct-nct04811651- Content hash
18c5fca2ba4e792c5b2c9e30792b0695bd3ce9eb3fabb5300f20900de1d15970